FDA updates guidance on evaluating out-of-specification results for drugs The US Food and Drug Administration (FDA) has revised its 16-year-old final guidance on procedures for reviewing ...
Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice on creating a robust out-of-specification procedure. Welcome to ...
This course is designed to be an exploration of best practice for OOS investigations in a GMP environment. The course is aimed at the investigation of all out of expectation (OOE) results, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results